Company / Revenue per Share
Humana Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$1041.97
FY2025
5-year range
$580.06 / $1041.97
FY2021-FY2025
Trend
+12.5%
vs FY2024
Sector context
#3 of 154
Health Care
What the data says
Among 154 Health Care companies, Humana is in the top 2% for revenue per share. Revenue per Share has increased for 3 consecutive years, from $580.06 in FY2022 to $1041.97 in FY2025.
Based on SEC 10-K filings.
1041.97 in FY2025 with a 5-year CAGR of +13.3%. Ranks 3rd among 154 companies in Health Care.
Improved from $641.94 to $1041.97 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +21.6%
- 5-Year CAGR
- +13.3%
- 10-Year CAGR
- -
Sector benchmark
+740.4% above sector average
Key checks
Key Insights
- Humana's revenue per share has grown for 3 consecutive years.
- In FY2025, revenue per share increased 12.5% year-over-year.
- Ranks #3 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.80 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1041.97 | +12.5% |
| FY2024 | $926.57 | +44.3% |
| FY2023 | $641.94 | +10.7% |
| FY2022 | $580.06 | -5.9% |
| FY2021 | $616.54 | +10.6% |
| FY2020 | $557.47 | +50.9% |
| FY2019 | $369.32 | -2.1% |
| FY2018 | $377.11 | +5.0% |
| FY2017 | $359.19 | +3.0% |
| FY2016 | $348.87 | +34.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026